Bonney Michael W - Insider Stock Trading - OpenInsider

CIK: 1219016 - Address: 675 West Kendall Street, Henri A. Termeer Square, Cambridge, MA 02142

11 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	6	1	7	1	-2	2	-2	2	-6	-1
P	%wins				86	57	57	57	57	43	60

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
6/9/20 19:16	12/4/19	BMY	Bristol Myers Squibb Co	DE	Health	Drug	Pharmaceutical Preparations	Bonney Michael W	NY	D		P	5	58.90	0	0	1	9	D
9/9/19 14:18	9/9/19	SRPT	Sarepta Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Bonney Michael W	MA	D		P	173	86.74	0	2	40	7	D
3/4/19 20:13	2/28/19	KLDO	Kaleido Biosciences, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Bonney Michael W	MA	DO	Exec Cha	P.d	999	13.98	0	72	5	1,651	M
3/10/16 18:35	3/9/16	ALNY	Alnylam Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Bonney Michael W	MA	D		P	117	58.36	33	2	100	4	I	-17	-45	-43	-38	-14	-4	3	2	7	4	18	20	24	-11
3/4/16 16:33	3/3/16	CELG	Celgene Corp /de/	DE	Health	Drug	Pharmaceutical Preparations	Bonney Michael W	NJ	D		P	206	103.01	33	2	New	2	I	27	-14	-11	-7	-3	3	1	2	2	-2	-1	6	4	21
8/18/15 15:11	8/17/15	THW	Tekla World Healthcare Fund		Fund	CEF	Closed-End Funds	Bonney Michael W	MA	D		P	200	18.35	4	11	New	11	D					-8	-8	-8	-2	0	-13	-9	-15	-29	-12
5/13/15 18:00	5/12/15	ALNY	Alnylam Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Bonney Michael W	MA	D		P	224	112.16	33	2	New	2	I	344	98	19	22	9	-4	6	7	1	3	16	-7	-5	-53
7/29/14 16:28	7/28/14	THQ	Tekla Healthcare Opportunities Fund		Fund	CEF	Closed-End Funds	Bonney Michael W	MA	D		P	100	20.00	0	5	New	5	D
3/12/12 17:12	3/9/12	HQH	H&q Healthcare Investors	MA	Fund	CEF	Closed-End Funds	Bonney Michael W	MA	D		P	10	15.80	1	1	New	1	D	47	21	23	16	6	0	0	3	1	1	1	3	17	35
3/12/12 17:12	3/9/12	HQL	H&q Life Sciences Investors	MA	Fund	CEF	Closed-End Funds	Bonney Michael W	MA	D		P	11	13.25	1	1	New	1	D	52	25	27	16	5	0	0	3	0	0	1	6	20	34
5/19/05 16:24	5/17/05	NPSP	Nps Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Bonney Michael W	UT	D		P	52	12.95	4	4	New	4	D	-31	-41	-28	-11	0	7	-3	1	-2	-6	-11	-25	-20	-56

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact